M

MedImpact

Independent PBM reducing prescription costs

Principal Formulary Consulting

Full-Time
$114.6k - $160.5k+ Incentive compensation + 401(k) match
Expert
Bachelor's
Remote in USA
HybridRemote work requires management approval based on business requirements; domestic travel up to 10%.
ConsultingStrategy & Management Consulting
No H1B Sponsorship

About the job

Requirements
  • A Bachelor of Arts or Bachelor of Science degree and 8+ years of related experience, including 8+ years as a subject matter expert in the respective areas, or an equivalent combination of education and experience.
  • Strong knowledge of Microsoft Office Suite software, including Word, Excel, PowerPoint, and other applications.
  • Moderate experience with SQL, database applications, financial modeling tools, reporting platforms, and enterprise project tracking tools; advanced Excel skills are required.
  • A valid Registered Pharmacy license in any U.S. state.
  • Superior working knowledge of managed care pharmacy services, especially the relationship between managed health care and pharmacy benefit management, and expertise in advanced managed pharmacy practice and managed medical and prescription drug practices.
  • Good working knowledge of pharmacy services, especially in managed health care.
  • Expertise in the administrative and operational application of pharmacy practice.
  • Ability to persuasively present business propositions clearly and credibly in writing and verbally.
  • Ability to identify challenges and develop solutions using a consultative sales approach.
  • Pharmacy benefit management experience is required.
  • Ability to solve practical problems and deal with varied concrete situations where standardization is limited.
  • Ability to interpret written, oral, diagrammatic, or scheduled instructions.
  • Ability to work with probability, statistical inference, geometry, and trigonometry concepts.
  • Ability to apply fractions, percentages, ratios, and proportions to practical situations.
  • Ability to read, analyze, and interpret business periodicals, professional journals, technical procedures, and government regulations.
  • Ability to write reports, business correspondence, and procedure manuals.
  • Ability to sit, talk, hear, stand, walk, use hands to handle objects, reach, and occasionally lift or move up to 25 pounds; maintain close visual acuity, color vision, and depth perception.
  • Must work the hours needed to complete responsibilities and deadlines, with flexibility to work beyond traditional hours, including nights, weekends, or holidays; typical core hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
  • Must provide adequate support to internal clients and be available for regular coordination with colleagues, clients, or vendors.
  • Requires domestic travel of up to 10% of the time.
Responsibilities
  • Identify, develop, and execute initiatives to optimize rebate yields and administrative fee revenue, including developing and delivering financial and clinical value propositions for rebate and formulary alignment opportunities to internal and external stakeholders responsible for formulary placement decisions.
  • Work independently and with pharmaceutical manufacturers and rebate vendors to develop and implement processes, products, and methods that support rapid utilization conversions after formulary placement changes and optimize rebate production.
  • Serve as an internal and external subject matter expert for the company and client plans on contractual rebate terms, conditions, requirements, interpretation, compliance, and rebate strategies; communicate directly with high-profile and strategic clients to educate, inform, recommend, and persuade them to adopt rebate-yield-improving changes.
  • Communicate tactical solutions to optimize rebate yield and reduce drug spend through formulary management and pull-through initiatives to enterprise stakeholders, including Formulary Services and Drug Information, and rebate clients in coordination with Account Management teams.
  • Model rebates, net spend, and disruption using internal and external rebate contract terms and client utilization, and present modeling results and recommendations to clients and account teams; analyze performance and trends for internal and externally sourced rebates and administrative fees.
  • Develop strategic and tactical solutions with the Director, Industry Relations and the Formulary Business Review Committee to optimize rebate yield and reduce drug spend through contract design, coordinated formulary management, and clinical or utilization edits across Commercial, Medicare, Medicaid, and Health Exchange lines of business.
  • Develop strategic and operational solutions for risk-based contracting and other innovative contracting initiatives supporting emerging rebate propositions.
  • Manage Formulary and Rebate Optimization staff to achieve unit and company goals and objectives.
  • Collaborate with Rebate Operations management to evaluate contract rebate eligibility for individual client plans, support accurate rebate qualification and calculation, contribute to quality assurance for rebate billing, and support rebate initiatives with account management teams and other contracting-strategy activities.
  • Support other departments by establishing and cultivating opportunities related to pharmaceutical-supported initiatives, including Medical Management coordination, Patient Care Center alignment, executive business briefings, communication and coordination of limited distribution drug channels, member support programs involving Centers of Excellence, and pharmacoeconomic analysis projects.
  • Participate in formulary strategy development to identify opportunities that improve rebate yield and reduce client net costs for MedImpact Standard formularies under direct and indirect rebate agreements.
  • Participate in the Formulary Business Review Committee by recommending MedImpact Standard Formulary changes and changes for aligned clients with custom formularies, and facilitate implementation of approved changes with pull-through support.
  • Coordinate with subsidiary and related companies on Industry Relations strategies to enhance and optimize value creation across the enterprise.
  • Participate as a subject matter expert on the Formulary Committee by supporting product placement decisions through financial, spend, utilization, and rebate models; recommending formulary management for individual drugs and therapeutic classes; sharing market intelligence and industry analysis; and contributing to formulary strategy concepts and features that support optimal rebate performance.
  • Participate in and lead the annual Part D formulary strategy process to identify product placement opportunities that improve rebate yield and reduce client net costs.
  • Support rebate audits conducted by clients, pharmaceutical manufacturers, and CMS by interpreting rebate contract language as it applies to individual client formularies.

About the company

MedImpact is an independent pharmacy benefit manager (PBM) serving health plans, self-funded employers, and government entities. It designs and administers prescription drug benefits to lower costs and improve member health, including core PBM services, clinical programs, and specialty drug management. It operates at a large scale with transparency and flexible pricing, negotiating rebates and processing claims for clients. Its goal is to reduce prescription drug costs while improving health outcomes through data-driven, end-to-end benefit management.

Company Size

1,001-5,000

Company Stage

Seed

Total Funding

$2.8M

Headquarters

San Diego, California

Founded

1989

Get referred to MedImpact

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Claria launched September 29, 2026 with claim-level rebate transparency and PMPM guarantees.
  • HCG X won PBMI’s 2026 award after 80.6% PMPQ savings and 5:1 ROI.
  • September 24, 2026 hiring of Rebekah Gregg accelerates commercialization of new digital offerings.

What critics are saying

  • The planned Medical Card System purchase adds $2.2 billion second-lien debt in 2026.
  • Puerto Rico Medicare Advantage integration creates execution risk across regulators, networks, and claims systems.
  • If employers reject rebate-driven PBMs, MedImpact’s margin base shrinks and scale erodes.

What makes MedImpact unique

  • Claria’s four pricing models give buyers rebate, guarantee, and control choices.
  • MedImpact remains the largest independent PBM, serving 20 million members.
  • URAC’s 2026 perfect accreditation score signals disciplined operations and quality control.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

Unlimited Paid Time Off

Paid Vacation

401(k) Company Match

Life Insurance

Disability Insurance

Tuition Reimbursement

Employee Referral Bonus

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

12%

2 year growth

13%
Access Market Intelligence
Oct 2nd, 2026
MedImpact launches Claria, a new approach to transform PBM economics.

MedImpact launches Claria, a new approach to transform PBM economics. Serving more than 20 million members and processing more than $40 billion in pharmacy transactions annually, MedImpact has the scale, resources, technology, and solutions to provide payers a better choice in the market for pharmacy benefits and health solutions. MedImpact recently introduced Claria, an industry-first approach that transforms PBM economics by giving plan sponsors the increased transparency, control, and predictability they need to confidently manage pharmacy spend in today's healthcare landscape. The company believes payers should not choose between rebates, flexibility, and financial certainty. That's why Claria offers four configurable models, all with transparent pricing, to meet each organization's unique needs: * Claria Direct - Designed for organizations that want to maximize control over their pharmacy strategy, Claria Direct offers the ability to customize formularies, networks, dispensing channels, and value-added services. * Claria Assure - Offers modernized pricing strategies with the flexibility to customize program features all with the financial confidence of guarantees. * Claria One - A PMPM guarantee and a formulary strategy built around lower-cost therapeutic options designed for organizations seeking the highest level of financial accountability and cost management. * Claria Align - By guaranteeing a plan's PMPM spend dollar for dollar, Claria Align delivers the highest level of accountability in the portfolio and is designed to deliver the lowest pharmacy costs. In August 2026, Yahoo Finance reported that MedImpact was in talks to receive a $2.2 billion second-lien private credit loan to support the company's proposed acquisition of Medical Card System, a healthcare services organization. Medical Card System, owned by Kinderhook-backed MHH Healthcare, offers insurance plans and managed care for Medicare Advantage members in Puerto Rico. #MedImpact #PBM #Claria #pharmacybenefit #transparency #medicalcardsystem

The Mirror Democrat and Savanna Times-Journal
Sep 29th, 2026
MedImpact launches Claria(TM), a distinctively new approach to delivering pharmacy benefits.

MedImpact launches Claria(TM), a distinctively new approach to delivering pharmacy benefits. * 5 hrs ago MedImpact, the nation's largest independent pharmacy benefit and health solutions company, today introduced Claria(TM), an industry-first approach that transforms PBM economics by giving plan sponsors the increased transparency, control, and predictability they need to confidently manage pharmacy spend in today's healthcare landscape. "Claria provides a new way of delivering pharmacy benefits to our clients. It brings together the scale of MedImpact's organization to deliver competitive economics with the flexibility for clients to choose the model that meets their needs. Most importantly, Claria is designed to align our compensation with our clients' goals of managing pharmacy spend, controlling trend, and improving access to care," said MedImpact Executive Vice President Zach Johnson. "Plan sponsors gain visibility into the true net cost of medications, greater control over clinical strategies, and enhanced budget predictability." Predictability Without Compromise. Mycarrollcountynews believe payers should not have to choose between rebates, flexibility, and financial certainty. That's why Claria offers four configurable models, all with transparent pricing, to meet each organization's unique needs: * Claria Direct - Designed for organizations that want to maximize control over their pharmacy strategy, Claria Direct offers the ability to customize formularies, networks, dispensing channels, and value-added services. * Claria Assure - Offers modernized pricing strategies with the flexibility to customize program features all with the financial confidence of guarantees. * Claria One - A PMPM guarantee and a formulary strategy built around lower-cost therapeutic options designed for organizations seeking the highest level of financial accountability and cost management. * Claria Align - By guaranteeing a plan's PMPM spend dollar for dollar, Claria Align delivers the highest level of accountability in the portfolio and is designed to deliver the lowest pharmacy costs. Informed Decision Making. Claim-level rebate transparency provides visibility into the net cost of every medication, enabling more informed financial and clinical decision-making. Plan Control Over Pharmacy Strategy. Plans may implement formulary, utilization management, biosimilar, and network strategies based on their organization's needs. Aligned Incentives. Claria aligns PBM compensation with services and solutions rather than drug mix, creating a stronger partnership with a continued focus on managing cost, trend, and outcomes. Member Affordability. Mycarrollcountynews recognize that its clients value and prioritize affordable pharmacy benefits for their members. Claria will position MedImpact to lay the foundation that aligns and empowers Mycarrollcountynews to build pharmacy plans that prefer the lowest cost, and therapeutically appropriate medication now more than ever. "MedImpact has been an independent company for nearly 40 years, and we have been committed to delivering clarity and control to our clients since our inception," said Johnson. "With Claria, we are taking that commitment to an entirely new level and providing clients with even greater flexibility and freedom to navigate today's healthcare landscape." About MedImpact San Diego-based MedImpact Healthcare Systems, Inc. is the nation's largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs. Today, MedImpact serves more than 20 million members and processes more than $40 billion in pharmacy transactions annually. To learn more, visit Mycarrollcountynews online, follow Mycarrollcountynews on LinkedIn, or contact Mycarrollcountynews at [email protected]. Media gallery

MedImpact
Sep 24th, 2026
MedImpact names Rebekah Gregg Senior Vice President of Marketing and Digital Solutions.

MedImpact names Rebekah Gregg Senior Vice President of Marketing and Digital Solutions. Pharmacy benefits executive will help the company communicate its affordability, technology, and clinical solutions to a healthcare industry undergoing change SAN DIEGO, CA - September 24, 2026 - MedImpact, the nation's largest independent pharmacy benefit and health solutions company, has named Rebekah Gregg Senior Vice President of Marketing and Digital Solutions. Gregg joins as MedImpact brings to market new solutions that give healthcare payers greater visibility, choices, and control over pharmacy benefits and lower costs for both members and plans. "Rebekah has spent much of her career working closely with payers and knows what challenges our clients face, what they need, and how to communicate it clearly," said MedImpact Executive Vice President Zach Johnson. "Her timing is excellent. We have exciting work underway and she is the right person to help us bring new solutions to the market." Payers today are facing rising drug prices, new therapies with historically high price tags, changing regulatory and marketplace dynamics, and an affordability crisis for members at the counter. An independent company for nearly 40 years, MedImpact is taking bold action by re-engineering the drug supply chain and rolling out new technologies, formularies, models, and clinical programs. Rebekah's expertise will be critical in communicating the value of the company's innovative solutions to the marketplace. Gregg joins MedImpact from Pharmaceutical Strategies Group (PSG), an EPIC company, where she served as Chief Operating Officer. In that role, she oversaw marketing, research, and operations, and an analytics platform that was used by payers covering more than 16 million members. She also led the firm's research and satisfaction studies, giving her a close view of what plan sponsors look for in pharmacy benefit partners. Keep up to date on the latest in the industry. Press Releases Claria transforms PBM economics by giving plan sponsors the transparency, control, and predictability they need to maximize their investment in medications Press Releases HCG X program provides payers 80.6% PMPQ savings and a 5:1 ROI in year one Press Releases Leveraging supply chain innovation and award-winning lifestyle management program, new solutions deliver lower costs, improved clinical care, and greater member access Press Releases By re-engineering the drug supply chain and formularies, Patel and the MedImpact team are increasing transparency, predictability and affordability

MedImpact
Sep 11th, 2026
MedImpact wins 2026 PBMI Excellence Award for high-cost generics solution.

MedImpact wins 2026 PBMI Excellence Award for high-cost generics solution. HCG X program provides payers 80.6% PMPQ savings and a 5:1 ROI in year one SAN DIEGO, CA - September 11, 2026 - MedImpact, the nation's largest independent pharmacy benefits and health solutions company, today announced that HCG X(R), a clinically driven solution that delivers significant savings on high-cost generic (HCG) medications, has won the 2026 Pharmacy Benefit Management Institute(R)(PBMI) Excellence Award for Cost Containment. "Despite common misconceptions, not all generic drugs are inexpensive. In fact, some are much more costly than therapeutically equivalent products," said Arpit Patel, Senior Vice President, Trade Relations and Supply Chain. "As specialty drugs and GLP-1s cause pharmacy spend to spiral, our HCG solutions are delivering real savings with little to no member disruption." Using advanced analytics to track prices and claim costs for more than 2,000 drugs, HCG X excludes high-cost generics when there are clinically appropriate, lower-cost alternatives. After just one year using the HCG X program, clients experienced an average of 80.6% reduction in per member per quarter (PMPQ) spend-and greater than 5:1 ROI. One hundred percent of clients reported satisfaction with this solution, citing its value, level of support, and financial impact. "Our HCG solution is another example of our drive to lower costs without compromising access," continued Patel. "And it is further proof that payers shouldn't have to choose between lower costs and quality care." Each year, the PBMI Excellence Awards recognize organizations demonstrating innovation and leadership, and making a measurable impact on the pharmacy benefit management industry. MedImpact was also recognized in 2025 for its MedEmpower Fuel(R) personalized health and wellness app. Keep up to date on the latest in the industry. Press Releases Leveraging supply chain innovation and award-winning lifestyle management program, new solutions deliver lower costs, improved clinical care, and greater member access Press Releases By re-engineering the drug supply chain and formularies, Patel and the MedImpact team are increasing transparency, predictability and affordability Client News Biosimilars represent one of the most powerful opportunities to reduce specialty drug costs for payers and members and expand access to effective t Press Releases Strategic expansion strengthens proximity to major East Coast employers and payers while enhancing service for clients east of the Mississippi

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.